ROC Analysis for Evaluation of Radiation Biodosimetry Technologies.

Receiver operating characteristic (ROC) analysis is a fundamental tool used for the evaluation and comparison of diagnostic systems that provides estimates of the combinations of sensitivity and specificity that can be achieved with a given technique. Along with critical considerations of practical limitations, such as throughput and time to availability of results, ROC analyses can be applied to provide meaningful assessments and comparisons of available biodosimetry methods. Accordingly, guidance from the Food and Drug Administration to evaluate biodosimetry devices recommends using ROC analysis. However, the existing literature for the numerous biodosimetry methods that have been developed to address the needs for triage either do not contain ROC analyses or present ROC analyses where the dose distributions of the study samples are not representative of the populations to be screened. The use of non-representative sample populations can result in a significant spectrum bias, where estimated performance metrics do not accurately characterize the true performance under real-world conditions. Particularly, in scenarios where a large group of people is screened because they were potentially exposed in a large-scale radiation event, directly measured population data do not exist. However, a number of complex simulations have been performed and reported in the literature that provide estimates of the required dose distributions. Based on these simulations and reported data about the output and uncertainties of biodosimetry assays, we illustrate how ROC curves can be generated that incorporate a realistic representative sample. A technique to generate ROC curves for biodosimetry data is presented along with representative ROC curves, summary statistics and discussion based on published data for triage-ready electron paramagnetic resonance in vivo tooth dosimetry, the dicentric chromosome assay and quantitative polymerase chain reaction assay. We argue that this methodology should be adopted generally to evaluate the performance of radiation biodosimetry screening assays so that they can be compared in the context of their intended use.

[1]  C. Beinke,et al.  Laboratory Intercomparison of the Dicentric Chromosome Analysis Assay , 2013, Radiation research.

[2]  Ann Barry Flood,et al.  Advances in in vivo EPR Tooth BIOdosimetry: Meeting the targets for initial triage following a large-scale radiation event. , 2016, Radiation protection dosimetry.

[3]  James Armitage,et al.  Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group , 2004, Annals of Internal Medicine.

[4]  Brian R. Moyer,et al.  RAPID RADIATION DOSE ASSESSMENT FOR RADIOLOGICAL PUBLIC HEALTH EMERGENCIES: ROLES OF NIAID and BARDA , 2010, Health physics.

[5]  H. Thierens,et al.  Laboratory Intercomparison of the Cytokinesis-Block Micronucleus Assay , 2013, Radiation research.

[6]  Michael C Joiner,et al.  Accurate gene expression-based biodosimetry using a minimal set of human gene transcripts. , 2014, International journal of radiation oncology, biology, physics.

[7]  Ann Barry Flood,et al.  In vivo EPR tooth dosimetry for triage after a radiation event involving large populations , 2014, Radiation and environmental biophysics.

[8]  K Rothkamm,et al.  Laboratory Intercomparison of Gene Expression Assays , 2013, Radiation research.

[9]  H Thierens,et al.  Comparison of Established and Emerging Biodosimetry Assays , 2013, Radiation research.

[10]  John F Koerner,et al.  Assessment of Biodosimetry Methods for a Mass-Casualty Radiological Incident: Medical Response and Management Considerations , 2013, Health physics.